Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SynKIR-110 |
Trade Name | |
Synonyms | SynKIR110|SynKIR 110 |
Drug Descriptions |
SynKIR-110 comprises autologous T-lymphocytes engineered to express a killer cell immunoglobulin-like receptor (KIR)-based chimeric antigen receptor (CAR) targeting MSLN, which potentially induce killing of tumor cells expressing MSLN (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C192653 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SynKIR-110 | SynKIR-110 | 0 | 1 |